معرفی
Clive Ballard is a Professor of Age Related Diseases at King’s College London, serving as Co-Director of the Biomedical Research Unit for Dementia (BRU-D) and the Wolfson Centre for Age Related Diseases. He previously led the Alzheimer’s Society’s research division (2003–2013). His work focuses on dementia with Lewy bodies, vascular dementia, and neuropsychiatric symptoms, with over 500 publications in top journals like Nature and the Lancet. He leads major clinical trials and drug discovery programs, emphasizing evidence-based treatments and reducing antipsychotic harms in dementia patients. His research network includes extensive collaborations in care homes and industry partnerships.
- Affiliations: King’s College London, South London & Maudsley NHS Foundation Trust, Alzheimer’s Society.
- Key Roles: Co-Director BRU-D, Chair of BRU-D Management Board, Lead for Synuclein Dementia Theme.
- Funding: NIHR, MRC, Wellcome Trust, EU, and industry grants.
Research interests span dementia subtypes, clinical trial design, and innovative therapies. His contributions include highlighting antipsychotic risks and advocating for safer alternatives, reshaping clinical practices globally.
Recent projects include exploring stem cell therapies, neuroinflammatory pathways in Alzheimer’s, and precision medicine approaches for Alzheimer’s patients with insulin resistance.
He advises international committees on drug safety and sits on advisory boards for major pharmaceutical companies (e.g., Janssen, Novartis).
Lab affiliations include the Wolfson Centre and collaborations with the Biomedical Research Centre for Mental Health.
